MPC1L
geneOn this page
Also known as SLC54A3
Summary
MPC1L (mitochondrial pyruvate carrier 1 like, HGNC:44205) is a protein-coding gene on chromosome Xp11.4, encoding Mitochondrial pyruvate carrier 1-like protein (P0DKB6). Mediates the uptake of pyruvate into mitochondria.
Predicted to enable pyruvate transmembrane transporter activity. Involved in mitochondrial pyruvate transmembrane transport. Located in mitochondrial inner membrane.
Source: NCBI Gene 347411 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 2 total
- MANE Select transcript:
NM_001195522
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:44205 |
| Approved symbol | MPC1L |
| Name | mitochondrial pyruvate carrier 1 like |
| Location | Xp11.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | SLC54A3 |
| Ensembl gene | ENSG00000238205 |
| Ensembl biotype | protein_coding |
| OMIM | 301103 |
| Entrez | 347411 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000423387
RefSeq mRNA: 1 — MANE Select: NM_001195522
NM_001195522
CCDS: CCDS83466
Canonical transcript exons
ENST00000423387 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001620310 | 40623428 | 40624136 |
Expression profiles
Bgee: expression breadth broad, 48 present calls, max score 94.47.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0544 / max 50.1582, expressed in 4 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 195997 | 0.0326 | 4 |
| 195998 | 0.0129 | 4 |
| 195999 | 0.0089 | 3 |
Top tissues by expression
95 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 94.47 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 88.11 | gold quality |
| left testis | UBERON:0004533 | 83.73 | gold quality |
| testis | UBERON:0000473 | 83.13 | gold quality |
| right testis | UBERON:0004534 | 83.07 | gold quality |
| granulocyte | CL:0000094 | 56.18 | gold quality |
| stromal cell of endometrium | CL:0002255 | 41.77 | silver quality |
| right coronary artery | UBERON:0001625 | 39.63 | silver quality |
| sural nerve | UBERON:0015488 | 37.26 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 37.12 | silver quality |
| mucosa of stomach | UBERON:0001199 | 36.49 | silver quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| placenta | UBERON:0001987 | 33.29 | gold quality |
| islet of Langerhans | UBERON:0000006 | 33.27 | gold quality |
| right uterine tube | UBERON:0001302 | 32.86 | gold quality |
| lymph node | UBERON:0000029 | 32.66 | silver quality |
| leukocyte | CL:0000738 | 32.60 | silver quality |
| blood | UBERON:0000178 | 32.15 | gold quality |
| monocyte | CL:0000576 | 31.74 | silver quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| kidney | UBERON:0002113 | 30.74 | silver quality |
| adult mammalian kidney | UBERON:0000082 | 30.29 | silver quality |
| right lobe of liver | UBERON:0001114 | 29.92 | silver quality |
| primary visual cortex | UBERON:0002436 | 29.85 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
10 targeting MPC1L, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-548AU-3P | 99.70 | 68.22 | 1373 |
| HSA-MIR-452-5P | 99.65 | 69.63 | 1762 |
| HSA-MIR-4676-3P | 99.65 | 69.31 | 1733 |
| HSA-MIR-892C-3P | 99.65 | 69.38 | 1745 |
| HSA-MIR-10394-5P | 99.65 | 66.83 | 1852 |
| HSA-MIR-1205 | 99.65 | 66.76 | 1826 |
| HSA-MIR-657 | 99.48 | 66.02 | 848 |
| HSA-MIR-3661 | 97.83 | 67.30 | 705 |
| HSA-MIR-631 | 97.05 | 66.93 | 602 |
| HSA-MIR-106B-3P | 82.36 | 64.48 | 34 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Gm4984 | ENSMUSG00000079871 |
| rattus_norvegicus | Mpc1l | ENSRNOG00000023163 |
Paralogs (2): MPC1 (ENSG00000060762), MPC2 (ENSG00000143158)
Protein
Protein identifiers
Mitochondrial pyruvate carrier 1-like protein — P0DKB6 (reviewed: P0DKB6)
All UniProt accessions (1): P0DKB6
UniProt curated annotations — full annotation on UniProt →
Function. Mediates the uptake of pyruvate into mitochondria.
Subunit / interactions. Heterodimer; dimerises with MPC2 to form a functional mitochondrial pyruvate carrier.
Subcellular location. Mitochondrion inner membrane.
Similarity. Belongs to the mitochondrial pyruvate carrier (MPC) (TC 2.A.105) family.
RefSeq proteins (1): NP_001182451* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR005336 | MPC | Family |
Pfam: PF03650
Catalyzed reactions (Rhea), 1 shown:
- pyruvate(out) + H(+)(out) = pyruvate(in) + H(+)(in) (RHEA:64720)
UniProt features (8 total): topological domain 3, transmembrane region 2, chain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
4 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 9GIV | ELECTRON MICROSCOPY | 3.65 |
| 9GIX | ELECTRON MICROSCOPY | 3.65 |
| 9GIY | ELECTRON MICROSCOPY | 3.79 |
| 9GIW | ELECTRON MICROSCOPY | 3.92 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0DKB6-F1 | 61.48 | 0.01 |
Antibody-complex structures (SAbDab): 1 — 9GIX
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-70268 | Pyruvate metabolism |
| R-HSA-1428517 | Aerobic respiration and respiratory electron transport |
| R-HSA-1430728 | Metabolism |
MSigDB gene sets: 26 (showing top):
GOBP_MITOCHONDRIAL_TRANSPORT, GOBP_ORGANIC_ACID_TRANSPORT, GOBP_MITOCHONDRIAL_TRANSMEMBRANE_TRANSPORT, GOBP_ORGANIC_ANION_TRANSPORT, GOCC_MITOCHONDRIAL_ENVELOPE, GOBP_MONOCARBOXYLIC_ACID_TRANSPORT, GOBP_TRANSMEMBRANE_TRANSPORT, REACTOME_PYRUVATE_METABOLISM, GOCC_ORGANELLE_INNER_MEMBRANE, GOCC_INNER_MITOCHONDRIAL_MEMBRANE_PROTEIN_COMPLEX, GOCC_MEMBRANE_PROTEIN_COMPLEX, GOCC_MITOCHONDRIAL_PROTEIN_CONTAINING_COMPLEX, GOMF_MONOCARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_TRANSPORTER_ACTIVITY, GOCC_ORGANELLE_ENVELOPE
GO Biological Process (1): pyruvate import into mitochondria (GO:0006850)
GO Molecular Function (2): pyruvate transmembrane transporter activity (GO:0050833), protein binding (GO:0005515)
GO Cellular Component (3): mitochondrial inner membrane (GO:0005743), mitochondrion (GO:0005739), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Aerobic respiration and respiratory electron transport | 1 |
| Metabolism | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| pyruvate transmembrane transport | 2 |
| import into the mitochondrion | 1 |
| monocarboxylic acid transmembrane transporter activity | 1 |
| binding | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
286 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MPC1L | MPC2 | O95563 | 711 |
| MPC1L | DRC4 | O95995 | 376 |
| MPC1L | PC | P11498 | 376 |
| MPC1L | PDHA1 | P08559 | 359 |
| MPC1L | AASDH | Q4L235 | 348 |
| MPC1L | DNALI1 | O14645 | 329 |
| MPC1L | SPEF2 | Q9C093 | 321 |
| MPC1L | ACLY | P53396 | 315 |
| MPC1L | SPAG6 | O75602 | 309 |
| MPC1L | LDHA | P00338 | 300 |
| MPC1L | NDUFB2 | O95178 | 294 |
| MPC1L | PDK1 | Q15118 | 283 |
| MPC1L | DNAI2 | Q9GZS0 | 274 |
| MPC1L | PPARGC1A | Q9UBK2 | 269 |
| MPC1L | RSPH4A | Q5TD94 | 261 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MPC2 | MPC1L | psi-mi:“MI:0407”(direct interaction) | 0.650 |
ESM2 similar proteins: A5A761, A6QP55, A8E7G5, B2LU20, O01578, O13793, O14949, O74847, P0DKB6, P19783, P38857, P53157, P53311, P63030, P63031, Q09201, Q09896, Q12029, Q21828, Q28852, Q2L897, Q3ZCG2, Q54NQ9, Q54PP1, Q55GU3, Q55GU4, Q5E9M8, Q5EA43, Q5FC79, Q5R597, Q5RD16, Q63965, Q6FJJ0, Q6PDU7, Q759E9, Q7KSC4, Q7TQ16, Q91V61, Q925N2, Q949R9
Diamond homologs: O74847, P0DKB6, P53157, P53311, P63030, P63031, Q21828, Q2M2T3, Q3ZCG2, Q55GU4, Q7KSC4, Q949R9, Q9Y5U8, P38857, O01578, O49636, O95563, P38718, Q09896, Q5R4Z3, Q8L7H8, Q8LD38, Q9D023
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| MPC1L | “form complex” | “Mitochondrial pyruvate carrier complex, testis variant” | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
2 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
891 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:40623776:T:C | F71L | 0.957 |
| X:40623778:C:A | F71L | 0.957 |
| X:40623778:C:G | F71L | 0.957 |
| X:40623668:A:C | S35R | 0.924 |
| X:40623670:C:A | S35R | 0.924 |
| X:40623670:C:G | S35R | 0.924 |
| X:40623845:A:C | S94R | 0.919 |
| X:40623847:T:A | S94R | 0.919 |
| X:40623847:T:G | S94R | 0.919 |
| X:40623767:T:C | F68L | 0.906 |
| X:40623769:C:A | F68L | 0.906 |
| X:40623769:C:G | F68L | 0.906 |
| X:40623650:T:C | F29L | 0.871 |
| X:40623652:C:A | F29L | 0.871 |
| X:40623652:C:G | F29L | 0.871 |
| X:40623725:A:C | S54R | 0.855 |
| X:40623727:T:A | S54R | 0.855 |
| X:40623727:T:G | S54R | 0.855 |
| X:40623824:T:C | C87R | 0.819 |
| X:40623802:C:A | N79K | 0.797 |
| X:40623802:C:G | N79K | 0.797 |
| X:40623671:T:A | W36R | 0.794 |
| X:40623671:T:C | W36R | 0.794 |
| X:40623844:G:C | Q93H | 0.789 |
| X:40623844:G:T | Q93H | 0.789 |
| X:40623832:C:A | N89K | 0.788 |
| X:40623832:C:G | N89K | 0.788 |
| X:40623623:T:C | F20L | 0.780 |
| X:40623625:C:A | F20L | 0.780 |
| X:40623625:C:G | F20L | 0.780 |
dbSNP variants (sampled 300 via entrez): RS1000398916 (X:40623025 G>A,C), RS1003794941 (X:40623446 G>A,C), RS1007875655 (X:40622307 T>C), RS1007929629 (X:40622861 A>G), RS1008882109 (X:40624136 A>G), RS1010270905 (X:40622960 C>G), RS1010344536 (X:40622594 A>T), RS1010992590 (X:40624037 G>GA), RS1011398215 (X:40623677 C>T), RS1012512424 (X:40623547 C>A,T), RS1014141818 (X:40623059 C>G,T), RS1014187184 (X:40621517 C>T), RS1015193909 (X:40622354 C>G), RS1016607503 (X:40623448 G>C,T), RS1017289328 (X:40623856 C>G,T)
Disease associations
OMIM: gene MIM:301103 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: transporter — SLC54 Mitochondrial pyruvate carriers
Most potent curated ligand interactions (6 total), top 6:
| Ligand | Action | Affinity | Parameter |
|---|---|---|---|
| UK-5099 | Inhibition | 7.28 | pIC50 |
| zaprinast | Inhibition | 6.49 | pIC50 |
| entacapone | Inhibition | 6.2 | pIC50 |
| mitoglitazone | Inhibition | 5.57 | pIC50 |
| nitrofurantoin | Inhibition | 5.48 | pIC50 |
| lonidamine | Inhibition | 5.34 | pIC50 |
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects cotreatment, increases methylation | 1 |
| butyraldehyde | increases expression | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Rotenone | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Targeted by drugs: Entacapone, Lonidamine, Nitrofurantoin